Structure Database (LMSD)

LMSD: Structure-based search results

LM_ID	Common Name	Systematic Name	Formula	Mass	Main Class	Sub Class
LMFA04010006	11-F4-NeuroP	3-(3,5-dihydroxy-2-((1E,5Z,8Z,11Z)-3- hydroxytetradeca-1,5,8,11-tetraen-1-yl) cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010059	ent-11-F4t-NeuroP	3-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010060	ent-4-epi-11-F4c-NeuroP	3-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010061	ent-4-epi-11-F4t-NeuroP	3-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010062	ent-11-F4c-NeuroP	3-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010063	11-epi-11-F4c-NeuroP	3-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010064	4,11-diepi-11-F4t-NeuroP	3-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010065	4,11-diepi-11-F4c-NeuroP	3-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010066	11-epi-11-F4t-NeuroP	3-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010067	ent-11-epi-4-Ft-NeuroP	3-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010068	ent-4,11-diepi-4-Fc-NeuroP	3-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010069	ent-4,11-diepi-4-Ft-NeuroP	3-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010070	ent-11-epi-4-Fc-NeuroP	3-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010071	11-F4c-NeuroP	3-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010072	4-epi-11-F4t-NeuroP	3-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010073	4-epi-11-F4c-NeuroP	3-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010074	11-F4t-NeuroP	3-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S, 1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8, 11-tetraen-1-yl)cyclopentyl)propanoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]